It indicated that the expression of STEAP1 exhibited heterogeneity in urinary cancers such as renal cell carcinoma and female reproductive disorders such as breast invasive cancer, ovarian cancer, and endometrial carcinoma but consistency in digestive cancer types such as colorectal cancer and gastric cancer as well as respiratory cancers. This evidence concerns the gene STEAP1 and endometrial carcinoma.